Treatment of relapsed refractory multiple myeloma: which new PI-based combination treatments do patients prefer?

Treatment of relapsed refractory multiple myeloma: which new PI-based combination treatments do patients prefer?

Thomas Wilke,1 Sabrina Mueller,2 Sabine Bauer,2 Silvia Pitura,3 Leona Probst,3 Boris A Ratsch,3 Hans Salwender4 1Institut für Pharmakoökonomie und Arzneimittellogistik (IPAM), 23966 Wismar, Germany; 2Ingress-Health, 23966 Wismar, Germany; 3Takeda Pharma Vertrieb GmbH & Co....

Full description

Bibliographic Details
Main Authors: Wilke T, Mueller S, Bauer S, Pitura S, Probst L, Ratsch BA, Salwender H
Format: Article
Language:English
Published: Dove Medical Press 2018-11-01
Series:Patient Preference and Adherence
Subjects:
MM patient’s treatment preferences
relapsed refractory multiple myeloma (RRMM)
discrete choice experiment
DCE
Online Access:https://www.dovepress.com/treatment-of-relapsed-refractory-multiple-myeloma-which-new-pi-based-c-peer-reviewed-article-PPA

Internet

https://www.dovepress.com/treatment-of-relapsed-refractory-multiple-myeloma-which-new-pi-based-c-peer-reviewed-article-PPA

Similar Items